Melodiol Global Health: Global Portfolio of Strategic Cannabis and Plant-based Businesses Company News
COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care Psychedelics Investing
Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimer's Disease Psychedelics Investing
How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space Psychedelics Investing
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide Psychedelics Investing
One Year Into Kabir Nath’s Leadership, Compass Pathways’ Phase 3 Trial For Innovative Treatment Resistant Depression Progressing Psychedelics Investing
Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company Psychedelics Investing
COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression Psychedelics Investing
